Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
Roger Stupp MD
Roger Stupp MD Advisory Board
See All Experts
featured
Published in Oncology and
1 other channel

Expert Opinion / Interview · February 25, 2020

Durvalumab as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

Matthew Mossanen MD, MPH
Bradley McGregor MD

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Bradley McGregor MD

Further Reading

Related Videos